Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
86.79%
Operating Margin
4.39%
Net Margin
4.39%
Efficiency Metrics
Revenue per Expense Ratio
1.05
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
12.39%
Income Tax Rate
27.71%
EPS
1.9100000000
Balance Sheet Analysis
Current Ratio
45,582,000,000.0
Cash Ratio
2,505,000,000.0
Working Capital
$51.14B
Debt to Equity
0.62
Debt to Assets
5.31%
Equity Ratio
8.57%
Cash Flow Analysis
Operating Cash Flow Ratio
58.54%
Free Cash Flow Ratio
57.42%
CapEx to Revenue
1.12%
Dividends Paid
$500.00M
Stock Buybacks
$41.00M
Total Shareholder Returns
$541.00M
Cash Position Change
21.04%
Key Takeaways (2023 FY)
Increased dividend payments by 4.14%
Detailed Growth Metrics
Core Performance
Revenue
2.01%
Net Income
-60.05%
EPS
-59.45%
Operating Income
-68.59%
Operational Efficiency
R&D Expenses
0.00%
SG&A Expenses
-8.90%
Operating Cash Flow
48.75%
Free Cash Flow
50.49%
Balance Sheet Health
Assets
41.16%
Debt
17.10%
Book Value per Share
403.68%
Inventory
100.00%
Shareholder Returns
Dividends per Share
4.14%
Shares Outstanding
-1.82%
Long Term Trends
3Y Revenue/Share
15.04%
5Y Revenue/Share
56.95%
3Y Dividend/Share
35.20%
5Y Dividend/Share
54.13%